Hypertrophic Scar Treatment: Laser, Steroid and Silicone Protocol 2026

Quick Answer: A hypertrophic scar is a raised, erythematous scar type that remains within the original wound boundaries, resulting from disrupted collagen synthesis during wound healing. Its key distinction from a keloid is that it does not extend beyond the wound margins. First-line treatment is intralesional triamcinolone injection and silicone gel application; adding fractional laser to this combination markedly improves the response.

Hypertrophic scars are a common complication of surgical or burn injuries, particularly in the chest, shoulder, and chin regions. In addition to cosmetic concerns, they can also cause functional problems such as itching, pain, and restricted movement. Early intervention is the single most critical factor directly influencing treatment success. At Virtuana Clinic, we offer a comprehensive approach to scar treatment in Izmit–Kocaeli using combined protocols.

What Is a Hypertrophic Scar? Mechanism of Formation

Normal wound healing encompasses the phases of haemostasis, inflammation, proliferation, and remodelling. The remodelling phase lasts 12–18 months, during which collagen is both synthesised and degraded. In a hypertrophic scar, this balance is disrupted:

Overproduction of TGF-β1 and TGF-β2 → permanently activates fibroblasts.
As type III collagen synthesis increases, the collagen I/III ratio shifts; irregularly cross-linked collagen bundles form.
The longer myofibroblast activation persists, the greater the wound contraction — the scar remains raised.

Hypertrophic Scar vs Keloid: Comparison Table

Feature	Hypertrophic Scar	Keloid
Wound Boundaries	Does not exceed them	Exceeds them (extends to surrounding normal skin)
Growth	Limited; may flatten over time	May continue growing for years
Spontaneous Resolution	Possible (~50% — especially when tension decreases)	Rare
Location	Can occur anywhere	Chest, ear, shoulder, jaw, back
Family History	Absent or weak	Frequent (50%)
Skin Type	Equal frequency across all skin types	5–15 times more common in darker skin tones
Itching/Pain	Moderate	Pronounced; spontaneous pain may occur
Treatment Response	Good to moderate	Difficult; high tendency to recur

High-Risk Locations

Not every wound forms a hypertrophic scar. Risk is directly proportional to wound tension and dermal stress. Highest-risk areas include:

Chest/sternum region: Respiratory movements create constant tension; hypertrophic scars are common in sternotomy wounds.
Shoulder and deltoid region: Wide range of motion; continuous tension.
Jaw and neck: Tension is generated by speaking and swallowing movements.
Earlobe: Piercing site — one of the highest-risk areas for keloid as well.
Over joints: Elbow, knee — continuous stress during movement.

Treatment Options: Comprehensive Comparison

Treatment	Efficacy	Application Protocol	Side Effects	Priority
Silicone Gel / Sheet	High (preventive and therapeutic)	12+ hours/day, 3–6 months	Minimal; irritation rare	First-line (early phase)
Intralesional Triamcinolone	High (50–100% improvement)	10–40 mg/mL, every 4–6 weeks, 3–5 sessions	Atrophy, telangiectasia, hypopigmentation	First-line (active scar)
Fractional Laser (CO2 / Er:YAG)	High (tissue remodelling)	Every 6–8 weeks, 3–6 sessions	Redness 3–7 days, PIH risk	Second-line (combined with steroid)
Pulsed Dye Laser (PDL – 585/595 nm)	Moderate to high (vascular target)	Every 4–6 weeks, 3–5 sessions	Temporary bruising	For erythematous/vascular active scars
Cryotherapy	Moderate; effective for small scars	10–30 sec, every 4–6 weeks	Pain, hypopigmentation	Keloid + small hypertrophic scar
Intralesional 5-FU	Moderate to high; for steroid-resistant cases	50 mg/mL, every 4 weeks, 3–6 sessions	Local ulceration rare	Steroid-resistant or combination
Intralesional Verapamil	Moderate; collagen synthesis inhibitor	2.5 mg/mL, every 2 weeks	Minimal	Alternative when steroid is insufficient
Pressure Therapy	Moderate; particularly effective for burn scars	≥23 mmHg, 23 hours/day, 6–12 months	Comfort issues; compliance problems	Large-area burn scars

Combined Protocol: Steroid + Laser Synergy

Single-modality treatment yields limited responses for moderate-to-large hypertrophic scars. The Virtuana Clinic combined protocol:

In the same session: Fractional laser application → immediately followed by intralesional triamcinolone injection. After the laser perforates the scar tissue with microchannels, the steroid distributes more deeply and homogeneously.
Silicone gel: Applied for 12+ hours per day between sessions; supports repair after laser treatment.
Where indicated: PDL or 5-FU augmentation may be added at specific sessions.
Session interval: 4–6 weeks; total of 4–6 sessions.

This protocol achieves 60–80% volume reduction, colour normalisation, and resolution of itching and pain.

Early vs Late Scar Treatment

Timing is critically important:

Early intervention (4–8 weeks after wound closure): Silicone gel is started. The onset of hypertrophy is monitored. If erythema persists, PDL may be added. Intervention during this period can prevent the formation of a fully mature scar.
Active scar (3–12 months): Steroid + laser combined protocol. Because the scar is still active (red, raised, itchy), the response to treatment is highest during this period.
Mature scar (12 months+): The scar has faded and hardened. Fractional laser triggers tissue remodelling; however, the steroid effect diminishes. Surgical scar revision may become more feasible at this stage.

Scar Prevention: Post-Procedure Care Protocol

A protocol aimed at preventing hypertrophic scar formation in patients who have undergone surgery or sustained a deep laceration:

Immediately after suture removal (days 7–14): Silicone gel application is initiated.
Tension reduction: Perpendicular traction on the wound line is prevented with a scar-management bandage or medical tape.
UV protection: SPF 50+ is applied throughout wound healing; sun exposure accelerates hypertrophy.
Massage: Circular massage over the silicone (2 × 5 minutes per day) supports collagen remodelling.
Follow-up: Check-up every 4–6 weeks; immediate intervention if hypertrophy begins.

Preventing Recurrence

The greatest challenge in hypertrophic scarring is recurrence; return of the scar can be seen particularly between months 6 and 12 after steroid treatment ends. To prevent recurrence:

Silicone gel should be continued for at least 6 months after clinical treatment ends.
Elimination of sources of tension (inappropriate activity, poor suture planning).
Annual check-up sessions for early detection of re-activation.
Patients with darker skin tones (Fitzpatrick IV+) have a higher recurrence risk; more frequent monitoring is recommended.

Frequently Asked Questions

Can a hypertrophic scar be removed with surgery? Scar resection (surgical removal) is only indicated if the causative factors of the existing scar are eliminated; otherwise, a new scar generally re-forms at the same site.

Is botulinum toxin used in scar treatment? Yes; intralesional botulinum toxin A can suppress collagen synthesis by reducing myofibroblast activity. It can be used as an adjunct modality, particularly in high-tension areas.

How many sessions are needed before results are seen? The initial response (softening, colour lightening) is generally observed after 2–3 sessions. A complete protocol requires 4–6 sessions.

This article is for informational purposes only. Please consult a qualified physician for treatment decisions.